Our leadership

Cyril Titeux is Company Group Chairman, Johnson & Johnson Innovative Medicine Asia Pacific, and a member of the Innovative Medicine Group Operating Committee (GOC).

Joana leads the J&J Innovative Medicine ANZ team, where she drives sustained business growth that accelerates access to transformative innovations, and champions talent development to build a healthier future for patients.

Cherry Huang is the President of Johnson & Johnson Innovative Medicine China and a member of Johnson & Johnson Innovative Medicine Asia Pacific leadership team.

Amy Jackson is Head of Government Affairs and Policy for Innovative Medicine, Asia Pacific; and is a member of the Innovative Medicine Asia Pacific Leadership Team.

Yuri is a highly experienced leader recognised for her strong financial acumen, ability to nurture growth and passion for inclusive workplaces.

Yee Khun (Yeek) Lee is Vice President, Innovative Medicine Supply Chain Asia Pacific. Yeek is part of the Innovative Medicine Supply Chain and Innovative Medicine Asia Pacific Leadership Teams.

HyangWon (Harriet) Min is Vice President of Regulatory Affairs, Innovative Medicine, Asia Pacific. She is responsible for leading the regional regulatory affairs organization covering all therapeutic areas in the Asia Pacific region. She is also a member of the Global Regulatory Affairs Senior Leadership Team.

Majed Nasr, Head of HR for Johnson & Johnson Innovative Medicine, Asia Pacific, is an accomplished professional with nearly 20 years’ experience spanning strategy consulting and Human Resources, primarily in the healthcare and public sector industries.

Tomas Pietak is HCC Regional Sector Lead, Innovative Medicine, Asia Pacific. In this role, Tomas is responsible for the APAC region as well as the cross-sector HCC team in Southeast Asia; and is a member of the Asia Pacific Leadership Team (APLT). He is based in Singapore.

Emma Press is Vice President Law for J&J Innovative Medicine Asia Pacific, responsible for leading the strategic priorities of the Global Legal Organization and for managing and overseeing the work of the APAC legal team. She is a member of the Asia Pacific Leadership Team (APLT).

As Area Managing Director, Innovative Medicine, Southeast Asia & India, Sarthak oversees the Company’s operations in these markets, and he is a member of the Innovative Medicine Asia Pacific Leadership Team.

Christian Rodseth is Managing Director of North Asia, responsible for the J&J Innovative Medicine organization in South Korea and leading the cluster that includes Hong Kong and Taiwan. He is a member of the Asia Pacific Leadership Team (APLT).

Shuhei is an experienced industry leader and advocate for the value of pharmaceutical innovation and importance of access to transformational medicines.

Neelesh Shanbhag is currently the CIO & VP of Business Technology for Innovative Medicine, Asia Pacific, he is responsible for the technology direction of the Innovative Medicine group within Asia Pacific, developing and implementing effective IT strategies to support the overall growth objectives of the Innovative Medicine business in the region.

Matt Sheroff and his team lead the evaluation process for regional business cases for mid- and late-stage assets for both regional and global business development (BD) opportunities, as well as supporting the ongoing life cycle management activities for the Innovative Medicine established products portfolio.

Matthias Skillecorn is VP, Head of Asia Pacific Strategy Organization (APSO) which includes Regional Therapeutic Area Leaders, Market Access and Medical Affairs teams.

Andrew leads the Pharmaceutical Communication and Public Affairs team (C&PA) across Asia Pacific to deliver powerful strategies that support patients, enhance access and accelerate the business.

Lihui Yu is Senior Director of Commercial Quality at Johnson & Johnson Innovative Medicine, Asia Pacific and a member of the Asia Pacific Leadership Team.